News
A broader political battle over Trump’s tariffs is emerging, a fight that will ultimately be determined by how the U.S.
U.S. wholesale inflation cooled last month, despite worries that President Donald Trump’s tariffs would push prices higher.
European Central Bank policymaker Joachim Nagel said that a "steady hand" was required to deal with the uncertainty unleashed by U.S. President Donald Trump's latest tariff threat, in comments to ...
The First Minister said there would be an opportunity to discuss tariffs, Gaza and Ukraine with the US president.
Cover Media US on MSN30m
Trump Slaps 19% Tariff on Indonesia, EU Threatens RetaliationPresident Donald Trump has announced a 19% tariff on goods from Indonesia, part of a broader push to reset U.S. trade ...
Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...
42m
NDTV Profit on MSNIndia US Trade Deal Live: Is Official Announcement On Cards? Trump's Indonesia Pact Fuels BuzzDonald Trump, while announcing a trade deal with Indonesia on Tuesday, said the US is working alone the "same line" with India.
According to a new CNN poll conducted by SSRS, roughly 6 in 10 Americans say they oppose the GOP domestic policy bill that ...
Inflation, as measured by the producer price index, declined by three-tenths of a percentage point to 2.3% for the year ending in June, signaling that the U.S. is evading pain from the tariffs imposed ...
47mon MSN
Gary Cohn, IBM vice chairman and former National Economic Council Director under President Trump, joins 'Squawk Box' to ...
The Canadian Press on MSN48m
World shares are mixed after US inflation update suggests tariffs are causing prices to riseShares were mixed Wednesday in Europe and Asia after an update on U.S. inflation pulled most Wall Street stocks lower, though gains for Nvidia pushed the Nasdaq to another record. The report ...
55m
Asianet Newsable on MSNJohnson & Johnson Reportedly Halves Its Forecast Of US Tariff Impact To $200M, Sparks Retail ChatterJ&J raised its 2025 adjusted profit and sales forecasts, driven by strong demand for its cancer drugs, such as Darzalex, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results